These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 17234755)

  • 1. Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation.
    Feng Y; Bommer GT; Zhai Y; Akyol A; Hinoi T; Winer I; Lin HV; Cadigan KM; Cho KR; Fearon ER
    Cancer Res; 2007 Jan; 67(2):482-91. PubMed ID: 17234755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas.
    Hendrix ND; Wu R; Kuick R; Schwartz DR; Fearon ER; Cho KR
    Cancer Res; 2006 Feb; 66(3):1354-62. PubMed ID: 16452189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival.
    Alves-Guerra MC; Ronchini C; Capobianco AJ
    Cancer Res; 2007 Sep; 67(18):8690-8. PubMed ID: 17875709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotensin receptor 1 gene activation by the Tcf/beta-catenin pathway is an early event in human colonic adenomas.
    Souazé F; Viardot-Foucault V; Roullet N; Toy-Miou-Leong M; Gompel A; Bruyneel E; Comperat E; Faux MC; Mareel M; Rostène W; Fléjou JF; Gespach C; Forgez P
    Carcinogenesis; 2006 Apr; 27(4):708-16. PubMed ID: 16299383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells.
    Aoki K; Aoki M; Sugai M; Harada N; Miyoshi H; Tsukamoto T; Mizoshita T; Tatematsu M; Seno H; Chiba T; Oshima M; Hsieh CL; Taketo MM
    Oncogene; 2007 May; 26(24):3511-20. PubMed ID: 17160019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIP49 regulates beta-catenin-mediated neoplastic transformation and T-cell factor target gene induction via effects on chromatin remodeling.
    Feng Y; Lee N; Fearon ER
    Cancer Res; 2003 Dec; 63(24):8726-34. PubMed ID: 14695187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
    Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
    Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer.
    Tsuchiya K; Nakamura T; Okamoto R; Kanai T; Watanabe M
    Gastroenterology; 2007 Jan; 132(1):208-20. PubMed ID: 17241872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
    Esufali S; Bapat B
    Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.
    González-Sancho JM; Aguilera O; García JM; Pendás-Franco N; Peña C; Cal S; García de Herreros A; Bonilla F; Muñoz A
    Oncogene; 2005 Feb; 24(6):1098-103. PubMed ID: 15592505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
    Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD
    BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of beta-catenin.
    Jin T; George Fantus I; Sun J
    Cell Signal; 2008 Oct; 20(10):1697-704. PubMed ID: 18555664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling.
    Herzig M; Savarese F; Novatchkova M; Semb H; Christofori G
    Oncogene; 2007 Apr; 26(16):2290-8. PubMed ID: 17043652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Intestinal Wnt/TCF Signature.
    Van der Flier LG; Sabates-Bellver J; Oving I; Haegebarth A; De Palo M; Anti M; Van Gijn ME; Suijkerbuijk S; Van de Wetering M; Marra G; Clevers H
    Gastroenterology; 2007 Feb; 132(2):628-32. PubMed ID: 17320548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells.
    Hu M; Kurobe M; Jeong YJ; Fuerer C; Ghole S; Nusse R; Sylvester KG
    Gastroenterology; 2007 Nov; 133(5):1579-91. PubMed ID: 17983805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas.
    Schwartz DR; Wu R; Kardia SL; Levin AM; Huang CC; Shedden KA; Kuick R; Misek DE; Hanash SM; Taylor JM; Reed H; Hendrix N; Zhai Y; Fearon ER; Cho KR
    Cancer Res; 2003 Jun; 63(11):2913-22. PubMed ID: 12782598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.
    Renard CA; Labalette C; Armengol C; Cougot D; Wei Y; Cairo S; Pineau P; Neuveut C; de Reyniès A; Dejean A; Perret C; Buendia MA
    Cancer Res; 2007 Feb; 67(3):901-10. PubMed ID: 17283120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
    Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
    Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.
    Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP
    Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.